Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $769.09 | 2 | 46.3% |
| Food and Beverage | $746.81 | 20 | 45.0% |
| Education | $144.89 | 1 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $927.02 | 3 | $0 (2024) |
| Medtronic USA, Inc. | $144.89 | 1 | $0 (2018) |
| Orthofix Medical, Inc. | $131.77 | 1 | $0 (2023) |
| Mylan Specialty L.P. | $131.55 | 6 | $0 (2024) |
| Grifols USA, LLC | $102.55 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $70.56 | 4 | $0 (2022) |
| PFIZER INC. | $62.17 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $39.19 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $26.31 | 1 | $0 (2024) |
| Respiratory Technologies, Inc. | $24.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $875.12 | 7 | Stryker Corporation ($769.09) |
| 2023 | $409.15 | 7 | Stryker Corporation ($157.93) |
| 2022 | $56.46 | 3 | Mylan Specialty L.P. ($33.74) |
| 2021 | $139.89 | 3 | Grifols USA, LLC ($102.55) |
| 2018 | $144.89 | 1 | Medtronic USA, Inc. ($144.89) |
| 2017 | $35.28 | 2 | Respiratory Technologies, Inc. ($24.78) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 05/07/2024 | Stryker Corporation | SALVATION (Device) | Travel and Lodging | Cash or cash equivalent | $12.89 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 03/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/16/2024 | Stryker Corporation | SALVATION (Device) | Travel and Lodging | Cash or cash equivalent | $756.20 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 11/08/2023 | Stryker Corporation | AIR (Device) | Food and Beverage | In-kind items and services | $157.93 | General |
| Category: KNEES | ||||||
| 09/27/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/22/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiovascular | ||||||
| 08/15/2023 | Orthofix Medical, Inc. | Physio-Stim (Device), Physio-Stim | Food and Beverage | In-kind items and services | $131.77 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 04/27/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/03/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: VACCINES | ||||||
| 01/18/2023 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/30/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $102.55 | General |
| Category: Pulmonology | ||||||
| 06/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2018 | Medtronic USA, Inc. | CAPSTONE (Device) | Education | In-kind items and services | $144.89 | General |
| Category: TL | ||||||
| 10/05/2017 | Respiratory Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.78 | General |
| Category: Airway Clearance Therapy | ||||||
| 01/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 429 | 666 | $312,854 | $75,869 |
| 2022 | 9 | 354 | 531 | $272,964 | $67,798 |
| 2021 | 12 | 434 | 684 | $330,852 | $85,758 |
| 2020 | 12 | 525 | 768 | $396,369 | $108,145 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 100 | 243 | $170,586 | $41,342 | 24.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 91 | $58,058 | $12,596 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 106 | $37,100 | $10,131 | 27.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 41 | 88 | $30,976 | $7,534 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 57 | $13,110 | $3,622 | 27.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 26 | 27 | $1,080 | $248.04 | 23.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 26 | 27 | $1,134 | $212.16 | 18.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 26 | 27 | $810.00 | $184.08 | 22.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 87 | 238 | $167,076 | $41,986 | 25.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 79 | 81 | $51,678 | $12,675 | 24.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 82 | $28,700 | $6,741 | 23.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 23 | 34 | $11,968 | $3,024 | 25.3% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 13 | 16 | $7,280 | $1,849 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 17 | $3,910 | $986.73 | 25.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 21 | 21 | $840.00 | $206.57 | 24.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 21 | 21 | $882.00 | $176.95 | 20.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 21 | 21 | $630.00 | $153.10 | 24.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 92 | 281 | $197,262 | $50,070 | 25.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 74 | 78 | $49,764 | $12,438 | 25.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 83 | 106 | $37,100 | $8,995 | 24.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 81 | $18,630 | $4,782 | 25.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 34 | $5,372 | $2,321 | 43.2% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 20 | 20 | $5,040 | $1,895 | 37.6% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 18 | 21 | $7,392 | $1,814 | 24.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,830 | $1,597 | 33.1% |
About Dr. Khalid Alhourani, MD
Dr. Khalid Alhourani, MD is a Critical Care Medicine healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831232636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Alhourani, MD has received a total of $1,661 in payments from pharmaceutical and medical device companies, with $875.12 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($769.09).
As a Medicare-enrolled provider, Alhourani has provided services to 1,742 Medicare beneficiaries, totaling 2,649 services with total Medicare billing of $337,570. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Warwick, RI
- Active Since 02/14/2007
- Last Updated 09/19/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1831232636
Products in Payments
- SALVATION (Device) $769.09
- AIR (Device) $157.93
- CAPSTONE (Device) $144.89
- Physio-Stim (Device) $131.77
- Prolastin-C Liquid (Biological) $102.55
- YUPELRI (Drug) $97.81
- XARELTO (Drug) $70.56
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $42.13
- Yupelri (Drug) $33.74
- BREZTRI (Drug) $26.31
- CAMZYOS (Drug) $25.00
- PREVNAR 20 (Biological) $20.04
- ELIQUIS (Drug) $14.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Warwick
Dr. Sterling Malish, M.d, M.D
Critical Care Medicine — Payments: $843.49
Dr. John Cece, Md, MD
Critical Care Medicine — Payments: $541.81
Omar Aggarwal, Crna, CRNA
Critical Care Medicine — Payments: $205.79
Gerald Weinhouse, Md, MD
Critical Care Medicine — Payments: $15.14
Michael Dacey, M.d, M.D
Critical Care Medicine
Deirdre Kelly
Critical Care Medicine